Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1560431rdf:typepubmed:Citationlld:pubmed
pubmed-article:1560431lifeskim:mentionsumls-concept:C0021242lld:lifeskim
pubmed-article:1560431lifeskim:mentionsumls-concept:C0020616lld:lifeskim
pubmed-article:1560431lifeskim:mentionsumls-concept:C0359086lld:lifeskim
pubmed-article:1560431lifeskim:mentionsumls-concept:C0600686lld:lifeskim
pubmed-article:1560431pubmed:issue7lld:pubmed
pubmed-article:1560431pubmed:dateCreated1992-5-12lld:pubmed
pubmed-article:1560431pubmed:abstractTextA series of pyrimido[1,2-a]indoles were synthesized and studied for their hypoglycemic activity following oral administration at a standard dose of 100 mg/kg to fed rats. The effect of 10-alkoxyalkyl, 10-alkyl, 10-aryl, and 3,3-dialkyl substitution on the activity of 10-hydroxypyrimido[1,2-a]indoles was investigated. Relative potencies of a number of the most active compounds were defined by three-point dose-response studies. The most potent compounds were those with either 3,3-dimethyl substituents, compounds 21, 22, and 38, or 3,3-spirocyclohexane substituents, compounds 39 and 49. 10-Aminopyrimido[1,2-a]indoles were in general less active than the 10-hydroxy analogues, and potency was further decreased by derivatizing the 10-amino group. The most potent 10-amino derivatives were 57 and 58.lld:pubmed
pubmed-article:1560431pubmed:languageenglld:pubmed
pubmed-article:1560431pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1560431pubmed:citationSubsetIMlld:pubmed
pubmed-article:1560431pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1560431pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1560431pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1560431pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1560431pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1560431pubmed:statusMEDLINElld:pubmed
pubmed-article:1560431pubmed:monthAprlld:pubmed
pubmed-article:1560431pubmed:issn0022-2623lld:pubmed
pubmed-article:1560431pubmed:authorpubmed-author:WhiteA CAClld:pubmed
pubmed-article:1560431pubmed:authorpubmed-author:LienE LELlld:pubmed
pubmed-article:1560431pubmed:authorpubmed-author:SteinerK EKElld:pubmed
pubmed-article:1560431pubmed:authorpubmed-author:BlackR MRMlld:pubmed
pubmed-article:1560431pubmed:authorpubmed-author:ToddR SRSlld:pubmed
pubmed-article:1560431pubmed:authorpubmed-author:CliffeI AIAlld:pubmed
pubmed-article:1560431pubmed:authorpubmed-author:MansellH LHLlld:pubmed
pubmed-article:1560431pubmed:issnTypePrintlld:pubmed
pubmed-article:1560431pubmed:day3lld:pubmed
pubmed-article:1560431pubmed:volume35lld:pubmed
pubmed-article:1560431pubmed:ownerNLMlld:pubmed
pubmed-article:1560431pubmed:authorsCompleteYlld:pubmed
pubmed-article:1560431pubmed:pagination1169-75lld:pubmed
pubmed-article:1560431pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1560431pubmed:meshHeadingpubmed-meshheading:1560431-...lld:pubmed
pubmed-article:1560431pubmed:meshHeadingpubmed-meshheading:1560431-...lld:pubmed
pubmed-article:1560431pubmed:meshHeadingpubmed-meshheading:1560431-...lld:pubmed
pubmed-article:1560431pubmed:meshHeadingpubmed-meshheading:1560431-...lld:pubmed
pubmed-article:1560431pubmed:meshHeadingpubmed-meshheading:1560431-...lld:pubmed
pubmed-article:1560431pubmed:meshHeadingpubmed-meshheading:1560431-...lld:pubmed
pubmed-article:1560431pubmed:meshHeadingpubmed-meshheading:1560431-...lld:pubmed
pubmed-article:1560431pubmed:meshHeadingpubmed-meshheading:1560431-...lld:pubmed
pubmed-article:1560431pubmed:meshHeadingpubmed-meshheading:1560431-...lld:pubmed
pubmed-article:1560431pubmed:meshHeadingpubmed-meshheading:1560431-...lld:pubmed
pubmed-article:1560431pubmed:meshHeadingpubmed-meshheading:1560431-...lld:pubmed
pubmed-article:1560431pubmed:year1992lld:pubmed
pubmed-article:1560431pubmed:articleTitleOral hypoglycemic agents. Pyrimido[1,2-a]indoles and related compounds.lld:pubmed
pubmed-article:1560431pubmed:affiliationDepartment of Medicinal Chemistry, Wyeth Research, Maidenhead, Berkshire, England.lld:pubmed
pubmed-article:1560431pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1560431pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:1560431lld:chembl